Clinical Trial Update: The Fibrin Pad CV Phase III Study [Phase 3]

View source ↗

Summary

Ethicon's fibrin pad CV completed its Phase III cardiovascular study, with trial results posted on 2017-08-15.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Drugs mentioned

• Fibrin Pad CV

Snippet

Sponsor: Ethicon, Inc. | Conditions: Cardiovascular Disease | Phase 3 | Status: COMPLETED | Results posted: 2017-08-15